Torres et al. found lysyl oxidase like 2 (LOXL2) to be overexpressed in CAFs of CRC samples, proposing it as a predictive prognostic factor in colon cancer patients [38]. This evidence concerns the gene LOXL2 and colorectal carcinoma.